Fludarabine-melphalan reduced-intensity conditioning matched sibling bone marrow stem cell transplantation is an effective treatment for myeloid disorders

被引：0
作者：
Malladi, R
Peniket, A
Collins, G
Littlewood, T
机构：
[1] John Radcliffe Hosp, Oxford OX3 9DU, England
[2] John Radcliffe Hosp Clin Haematol, Oxford, England
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [41] Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies
    Shin, D-Y
    Lee, J-H
    Park, S.
    Lee, J-O
    Moon, J-H
    Ahn, J-S
    Choi, Y.
    Song, I-C
    Shin, H-J
    Lee, W. S.
    Lee, H. S.
    Yoon, S-S
    BONE MARROW TRANSPLANTATION, 2018, 53 (02) : 207 - 212
  • [42] Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies
    D-Y Shin
    J-H Lee
    S Park
    J-O Lee
    J-H Moon
    J-S Ahn
    Y Choi
    I-C Song
    H-J Shin
    W S Lee
    H S Lee
    S-S Yoon
    Bone Marrow Transplantation, 2018, 53 : 207 - 212
  • [43] Busulfan, fludarabine, and melphalan are effective conditioning for pediatric and young adult patients with myeloid malignancies underdoing matched sibling or alternative donor transplantation
    Truscott, Laurel
    Pariury, Holly
    Hanmod, Santosh
    Davini, Monica
    de la Maza, Michelina
    Sapp, Lauren N.
    Staples, Kyleigh
    Proytcheva, Maria
    Katsanis, Emmanuel
    PEDIATRIC BLOOD & CANCER, 2023, 70 (02)
  • [44] Successful treatment of JMML with related bone marrow transplantation after reduced-intensity conditioning
    M Koyama
    T Nakano
    Y Takeshita
    A Sakata
    A Sawada
    M Yasui
    T Okamura
    M Inoue
    K Kawa
    Bone Marrow Transplantation, 2005, 36 : 453 - 454
  • [45] Efficacy and Safety of Hematopoietic Stem Cell Transplantation for Pediatric Bone Marrow Failure Syndromes Using a Reduced Intensity Conditioning Regimen with Fludarabine, Thiotepa, Melphalan, and ATG
    Schiff, Deborah
    Marion, Ayesha
    King, Catherine
    Gloude, Nicholas J.
    Leung, Wing H.
    Anderson, Eric
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S418 - S419
  • [46] Reduced-intensity conditioning with treosulfan and fludarabine prior to allogeneic stem cell transplantation in multiple myeloma patients
    Schmidt-Hieber, M
    Casper, J
    Trenschel, R
    Andreesen, R
    Einsele, H
    Kanz, L
    Fauser, A
    Uharek, L
    Thiel, E
    Blau, I
    BONE MARROW TRANSPLANTATION, 2006, 37 : S195 - S196
  • [47] Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
    Lee, Seung-Shin
    Jung, Sung-Hoon
    Do, Young Rok
    Kim, Dae Sik
    Lee, Ji Hyun
    Park, Han-Seung
    Moon, Joon Ho
    Yi, Jun Ho
    Park, Yong
    Koh, Youngil
    Yhim, Ho-Young
    Choi, Yunsuk
    Mun, Yeung-Chul
    Lee, Won-Sik
    Lee, Seok
    Yang, Deok-Hwan
    YONSEI MEDICAL JOURNAL, 2020, 61 (06) : 452 - 459
  • [48] Transplantation tolerance in allogeneic stem cell transplantation with reduced-intensity conditioning
    Laylor, R
    Dyson, P
    Dewchand, H
    Simpson, E
    Dazzi, F
    BONE MARROW TRANSPLANTATION, 2004, 33 : S74 - S75
  • [49] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Chichra, Akanksha
    Nayak, Lingaraj
    Kothari, Rushabh
    Kalantri, Siddhesh
    Bonda, Avinash
    Gokarn, Anant
    Punatar, Sachin
    Mirgh, Sumeet
    Jindal, Nishant
    Bagal, Bhausaheb
    Kannan, Sadhana
    Mathew, Libin
    Khattry, Navin
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (01) : 71 - 79
  • [50] Reduced-Intensity Conditioning With Fludarabine and Busulfan Versus Fludarabine and Melphalan for Patients With Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
    Baron, Frederic
    Labopin, Myriam
    Peniket, Andy
    Jindra, Pavel
    Afanasyev, Boris
    Sanz, Miguel A.
    Deconinck, Eric
    Nagler, Arnon
    Mohty, Mohamad
    CANCER, 2015, 121 (07) : 1048 - 1055
12345